
Roche Lung Cancer Drug Succeeds in Clinical Trial
Swiss pharmaceutical giant Roche just announced a breakthrough clinical trial success for divarasib, a new drug targeting a hard-to-treat form of lung cancer. The therapy showed promising results as a second-line treatment without introducing new side effects. ##













%2Ffile%2Fattachments%2F2992%2FCheslin-Kolbe-2-1_183491.jpg)


